Opioid abuse and overdose crisis: new treatment available-controversy continues between harm-reduction treatment and abstinence treatment.

Funding/financial disclosures:No funding was received for the preparation of this article. The author has no conflicts of interest relevant to the content of this article. *Editor’s note:For additional information on buprenorphine, see page 32 of this issue of ICNS to read this month’s The Interface column “Buprenorphine Treatment for Narcotic Addiction: Not Without Risks.”